151 related articles for article (PubMed ID: 26859408)
1. Absence of Tumor-Infiltrating Lymphocyte Is a Reproducible Predictive Factor for Sentinel Lymph Node Metastasis: A Multicenter Database Study by the Brazilian Melanoma Group.
Duprat JP; Brechtbülh ER; Costa de Sá B; Enokihara M; Fregnani JH; Landman G; Maia M; Riccardi F; Belfort FA; Wainstein A; Moredo LF; Steck H; Brandão M; Moreno M; Miranda E; Santos ID
PLoS One; 2016; 11(2):e0148160. PubMed ID: 26859408
[TBL] [Abstract][Full Text] [Related]
2. Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma.
Taylor RC; Patel A; Panageas KS; Busam KJ; Brady MS
J Clin Oncol; 2007 Mar; 25(7):869-75. PubMed ID: 17327608
[TBL] [Abstract][Full Text] [Related]
3. A retrospective, multicenter analysis of the predictive value of mitotic rate for sentinel lymph node (SLN) positivity in thin melanomas.
Wat H; Senthilselvan A; Salopek TG
J Am Acad Dermatol; 2016 Jan; 74(1):94-101. PubMed ID: 26542815
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma.
Han D; Zager JS; Shyr Y; Chen H; Berry LD; Iyengar S; Djulbegovic M; Weber JL; Marzban SS; Sondak VK; Messina JL; Vetto JT; White RL; Pockaj B; Mozzillo N; Charney KJ; Avisar E; Krouse R; Kashani-Sabet M; Leong SP
J Clin Oncol; 2013 Dec; 31(35):4387-93. PubMed ID: 24190111
[TBL] [Abstract][Full Text] [Related]
5. Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.
Mandalà M; Imberti GL; Piazzalunga D; Belfiglio M; Labianca R; Barberis M; Marchesi L; Poletti P; Bonomi L; Novellino L; Di Biagio K; Milesi A; Guerra U; Tondini C
Eur J Cancer; 2009 Sep; 45(14):2537-45. PubMed ID: 19553103
[TBL] [Abstract][Full Text] [Related]
6. The prognostic significance of tumor-infiltrating lymphocytes for primary melanoma varies by sex.
Sinnamon AJ; Sharon CE; Song Y; Neuwirth MG; Elder DE; Xu X; Chu EY; Ming ME; Fraker DL; Gimotty PA; Karakousis GC
J Am Acad Dermatol; 2018 Aug; 79(2):245-251. PubMed ID: 29518458
[TBL] [Abstract][Full Text] [Related]
7. High level of TILs is an independent predictor of negative sentinel lymph node in women but not in men.
Fortes C; Mastroeni S; Caggiati A; Passarelli F; Ricci F; Michelozzi P
Arch Dermatol Res; 2021 Jan; 313(1):57-61. PubMed ID: 32266533
[TBL] [Abstract][Full Text] [Related]
8. Validation of a scoring system to predict non-sentinel lymph node metastasis in melanoma.
Cadili A; McKinnon G; Wright F; Hanna W; Macintosh E; Abhari Z; Dabbs K
J Surg Oncol; 2010 Mar; 101(3):191-4. PubMed ID: 20039281
[TBL] [Abstract][Full Text] [Related]
9. Sentinel lymph node biopsy in patients with thin melanomas: Frequency and predictors of metastasis based on analysis of two large international cohorts.
Isaksson K; Nielsen K; Mikiver R; Nieweg OE; Scolyer RA; Thompson JF; Ingvar C
J Surg Oncol; 2018 Sep; 118(4):599-605. PubMed ID: 30196533
[TBL] [Abstract][Full Text] [Related]
10. Absence of Granzyme B positive tumour-infiltrating lymphocytes in primary melanoma excisional biopsies is strongly associated with the presence of sentinel lymph node metastasis.
van Houdt IS; Sluijter BJ; van Leeuwen PA; Moesbergen LM; Hooijberg E; Meijer CJ; de Gruijl TD; Oudejans JJ; Boven E
Cell Oncol; 2009; 31(5):407-13. PubMed ID: 19759420
[TBL] [Abstract][Full Text] [Related]
11. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection.
Debarbieux S; Duru G; Dalle S; Béatrix O; Balme B; Thomas L
Br J Dermatol; 2007 Jul; 157(1):58-67. PubMed ID: 17501957
[TBL] [Abstract][Full Text] [Related]
12. Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma.
Azimi F; Scolyer RA; Rumcheva P; Moncrieff M; Murali R; McCarthy SW; Saw RP; Thompson JF
J Clin Oncol; 2012 Jul; 30(21):2678-83. PubMed ID: 22711850
[TBL] [Abstract][Full Text] [Related]
13. Stratifying SLN incidence in intermediate thickness melanoma patients.
Chang JM; Kosiorek HE; Dueck AC; Leong SPL; Vetto JT; White RL; Avisar E; Sondak VK; Messina JL; Zager JS; Garberoglio C; Kashani-Sabet M; Pockaj BA
Am J Surg; 2018 Apr; 215(4):699-706. PubMed ID: 29502857
[TBL] [Abstract][Full Text] [Related]
14. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
[TBL] [Abstract][Full Text] [Related]
15. Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma.
Murali R; Haydu LE; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Thompson JF; Scolyer RA
Ann Surg; 2012 Jan; 255(1):128-33. PubMed ID: 21975320
[TBL] [Abstract][Full Text] [Related]
16. Sentinel lymph node biopsy for cutaneous melanoma: the Stanford experience, 1997-2004.
Berk DR; Johnson DL; Uzieblo A; Kiernan M; Swetter SM
Arch Dermatol; 2005 Aug; 141(8):1016-22. PubMed ID: 16103331
[TBL] [Abstract][Full Text] [Related]
17. Is the presence of tumor-infiltrating lymphocytes predictive of outcomes in patients with melanoma?
Morrison SL; Han G; Elenwa F; Vetto JT; Fowler G; Leong SP; Kashani-Sabet M; Pockaj BA; Kosiorek HE; Zager JS; Sondak VK; Messina JL; Mozzillo N; Schneebaum S; Han D;
Cancer; 2022 Apr; 128(7):1418-1428. PubMed ID: 35103302
[TBL] [Abstract][Full Text] [Related]
18. Prediction of non-sentinel node status and outcome in sentinel node-positive melanoma patients.
Roka F; Mastan P; Binder M; Okamoto I; Mittlboeck M; Horvat R; Pehamberger H; Diem E
Eur J Surg Oncol; 2008 Jan; 34(1):82-8. PubMed ID: 17360144
[TBL] [Abstract][Full Text] [Related]
19. The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma.
Paek SC; Griffith KA; Johnson TM; Sondak VK; Wong SL; Chang AE; Cimmino VM; Lowe L; Bradford CR; Rees RS; Sabel MS
Cancer; 2007 Jan; 109(1):100-8. PubMed ID: 17146784
[TBL] [Abstract][Full Text] [Related]
20. Tumor-infiltrating lymphocyte response in cutaneous melanoma in the elderly predicts clinical outcomes.
Grotz TE; Vaince F; Hieken TJ
Melanoma Res; 2013 Apr; 23(2):132-7. PubMed ID: 23344159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
